Skip to main content

Table 1 Percent probe copy gains and losses for each histological category (CIN1 - n = 10; CIN2/3 - n = 10; SCC - n = 10)

From: Analysis of genetic copy number changes in cervical disease progression

 

% of Samples with Probe Copy Gains

 

% of Samples with Probe Copy Loss

Probe

CINa1

CINa2-3

SCCb

Probe

CINa1

CINa2-3

SCCb

8q24

0

80

100

3p14.2

20

20

80

3q26

30

80

100

2q33-q34

11

11

20

5p13

30

80

100

Xq11-q12

22

0

20

5p15.2

40

80

100

3p21-p23

11

0

18

CEPc8

30

78

100

Xp22.3

20

0

11

CEPcX

50

75

100

1q41

0

0

10

CEPc10

18

70

100

7p12.3-p12.1

0

0

10

CEPc16

20

60

100

CEPc7

10

0

10

CEPc12

10

56

100

2q23-q37

0

10

0

CEPc6

10

50

100

6q16.3-q21.3

0

10

0

CEPc9

0

44

100

6p21.2

10

10

0

CEPc11

20

44

100

8q24.12-24.13

0

0

0

CEPc1

13

43

100

CEPc16

0

0

0

CEPc17

10

40

100

20q13.2-q13.3

0

0

0

CEPc7

30

60

91

CEPc15

0

0

0

20q13.2-q13.3

10

80

90

2p24.1

0

0

0

CEPc15

0

70

90

CEPc18

0

0

0

2p24.1

20

67

90

11p15.5

0

0

0

1q41

9

60

90

11q13

0

0

0

7p12.3-p12.1

10

60

90

1p31.1.1

0

0

0

Xq11-q12

11

60

90

4p16.3

0

0

0

CEPc18

11

60

90

11q23

0

0

0

11q13

27

60

90

4p15.3

0

0

0

11p15.5

18

50

90

3q26

10

0

0

11p23

45

30

90

5p13

10

0

0

6q16.3-q21.3

10

40

82

5p15.2

10

0

0

6p21.2

0

10

82

CEPc8

10

0

0

Xp22.3

0

70

80

CEPcX

10

0

0

1p31.1.1

9

70

80

CEPc12

10

0

0

4p15.3

20

50

80

CEPc11

10

0

0

4p16.3

30

50

80

CEPc9

10

0

0

2q23-q37

20

30

80

CEPc17

10

0

0

3p21-p23

14

86

55

CEPc6

10

0

0

2q33-q34

33

44

50

CEPc1

13

0

0

3p14.2

10

60

9

CEPc10

18

0

0

  1. a = cervical intraepithelial neoplasia
  2. b = squamous cell carcinoma
  3. c = centromeric probe